✦ LIBER ✦

Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study

✍ Scribed by C. Falandry; M. Debled; T. Bachelot; T. Delozier; J. Crétin; P. Romestaing; D. Mille; B. You; L. Mauriac; E. Pujade-Lauraine; G. Freyer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

0148 REACT study: A phase III multicentr

✍ G. von Minckwitz; B. Conrad; C. Denkert; H. Eidtmann; W. Eiermann; W. Harbeck; J 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Exemestane improves survival compared wi

✍ M Kaufmann; E Bajetta; L.Y Dirix; L.E Fein; S.E Jones; J Cervek; C Fowst; A Poll 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Phase III Study Comparing Exemestane Wit

✍ Ma, C.X.; Ellis, M.J. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 174 KB

First results of a randomized phase III

✍ R Paridaens; P Therasse; L Dirix; L Beex; M.J Piccart; D Cameron; T Cufer; K Roo 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Survival advantage of exemestane (EXE, A

✍ E. Bajetta; L.Y. Dirix; L.E. Fein; S.E. Jones; J. Cervek; M. Kaufmann; C. Fowst; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Fulvestrant plus anastrozole or placebo

✍ Johnston, Stephen RD; Kilburn, Lucy S; Ellis, Paul; Dodwell, David; Cameron, Dav 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 459 KB